In this article, we will discuss the 10 Worst Performing NASDAQ Stocks So Far in 2026.
On May 11, Dan Niles, Niles Investment Management Founder, joined CNBC’s ‘The Exchange’ to discuss the current behavior of technology stocks in the context of historical market bubbles. While the host notes that current earnings and cash flows are far superior to the Pets.com era of the 1990s, Niles maintained that there are distinct similarities to the late-stage internet build-out. He pointed out that after Netscape Navigator launched in late 1994, the NASDAQ rose 109% over the next 3 years, followed by massive gains of 40% in year 4 and 86% in year 5. Comparing this to the current era, he noted that since ChatGPT’s release at the end of 2022, the NASDAQ is already up 122%. Niles suggested that while the market may be in a bubble, it could continue to inflate a lot more before reaching its end, predicting at least one more strong year for the sector.
Niles identified a fundamental shift in AI technology as a primary driver of current market strength. He pointed to the finalization of OpenClaw on January 30th as a major catalyst that ushered in agentic AI. He differentiated this from traditional chat-based AI, explaining that while chat-based models simply provide answers to questions, agentic AI can perform complex tasks. This shift to agentic systems requires 10x to 100x more compute power. This is reflected in token generation data; Niles reported that token growth jumped from 20% in the two months before OpenClaw’s finalization to over 120% in the two months following it. He expects this major step change in token generation to support strong growth through the beginning of next year.
Our Methodology
We used screeners to identify NASDAQ stocks that have exhibited low year-to-date performance, and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds. The stocks are ranked in descending order of their share price performance.
Note: All data was sourced on May 12.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
10 Worst Performing NASDAQ Stocks So Far in 2026
10. Cyabra Inc. (NASDAQ:CYAB)
Year-to-Date Performance: -96.22%
Cyabra Inc. (NASDAQ:CYAB) is one of the worst performing NASDAQ stocks so far in 2026. On April 14, Cyabra signed an expanded two-year renewal agreement valued in the six figures with a leading management firm. The contract extends the company’s existing relationship to provide monitoring and protection services for high-profile individuals and their associated teams. Under the new terms, Cyabra will integrate real-time narrative intelligence and authenticity analysis to combat emerging digital threats.
The enhanced scope specifically targets the detection of impersonation, deepfakes, and AI-generated misinformation that can jeopardize reputations and commercial partnerships. By using AI-powered monitoring, the platform identifies inauthentic behavior and coordinated disinformation campaigns across social media and digital channels. This intelligence provides management teams with the evidence necessary to facilitate proactive alerts and takedown decisions.
CEO Dan Brahmy highlighted that the expansion addresses an escalating need for defense against GenAI-manipulated content. The company’s platform is designed to neutralize harmful narratives before they gain traction, protecting stakeholder trust and brand integrity. Cyabra Inc. (NASDAQ:CYAB) expects continued growth in demand for these authenticity verification services as the digital threat landscape for high-profile entities becomes increasingly complex.
Cyabra Inc. (NASDAQ:CYAB) provides enterprises and governments with tools to identify and mitigate manipulated online content, coordinated inauthentic behavior, and narrative distortion. The platform delivers evidence-based insights that enable teams to take swift, proportionate action against digital threats.
9. Aspire Biopharma Holdings (NASDAQ:ASBP)
Year-to-Date Performance: -96.83%
Aspire Biopharma Holdings (NASDAQ:ASBP) is one of the worst performing NASDAQ stocks so far in 2026. On April 27, Aspire Biopharma authorized a $5 million share repurchase program using existing cash. The board initiated the buyback due to confidence in the company’s financial strength, its drug development pipeline, and the potential value of its pending acquisition of Dura Driver Control Systems.
Aspire Biopharma Holdings (NASDAQ:ASBP) recently strengthened its position by securing $21 million in financing and regaining NASDAQ compliance. These milestones support a capital strategy focused on shareholder returns, portfolio diversification through the “Buzz Bomb” supplement line, and disciplined business development.
Clinical efforts remain centered on patent-pending sublingual delivery technology, with an NDA filing for its lead aspirin candidate expected in late 2026. Aspire is also developing sublingual versions of several generic medications and expanding its intellectual property across multiple drug classes.
Aspire Biopharma Holdings (NASDAQ:ASBP) is an early-stage company specializing in disruptive sublingual delivery mechanisms for faster-acting drug administration. Its portfolio includes soluble aspirin for cardiology and pain management, alongside a pipeline of formulations ranging from vitamins and hormones to semaglutide and pre-workout supplements.
Hedge Fund Resource Center